Ho Carole

Insider CIK 1724605 · NGM Director · DNLI Chief Medical Officer · BEAM Director · RPRX Director

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
RPRX Royalty Pharma plc	A Award	2026-06-05	2026-06-08	4,545	—	$0	4,545	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2025-08-13	2025-08-14	806	$14.64	$11.8K	216,585	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2025-08-12	2025-08-14	2,937	$13.58	$39.9K	217,391	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2025-08-05	2025-08-07	44,655	—	$0	62,500	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2025-08-05	2025-08-07	44,655	$0.68	$30.4K	220,328	SEC↗
RPRX Royalty Pharma plc	A Award	2025-07-31	2025-07-31	2,752	—	$0	2,752	SEC↗
RPRX Royalty Pharma plc	A Award	2025-07-31	2025-07-31	5,806	—	$0	8,558	SEC↗
BEAM Beam Therapeutics Inc.	A Award deriv	2025-06-04	2025-06-06	33,662	—	$0	33,662	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2025-01-07	2025-01-08	2,907	$20.81	$60.5K	175,673	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2025-01-06	2025-01-08	12,255	$20.22	$247.8K	178,580	SEC↗
DNLI Denali Therapeutics Inc.	A Award deriv	2025-01-03	2025-01-07	162,540	—	$0	162,540	SEC↗
DNLI Denali Therapeutics Inc.	A Award	2025-01-03	2025-01-07	54,180	—	$0	190,835	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2024-11-25	2024-11-27	17,845	—	$0	107,155	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2024-11-25	2024-11-27	17,845	$0.68	$12.1K	136,655	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2024-08-21	2024-08-22	5,907	$24.96	$147.4K	118,810	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2024-08-21	2024-08-22	14,098	$24.41	$344.1K	124,717	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2024-08-20	2024-08-22	2,453	$23.79	$58.4K	138,815	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2024-08-13	2024-08-15	2,337	$22.89	$53.5K	141,268	SEC↗
BEAM Beam Therapeutics Inc.	A Award deriv	2024-06-05	2024-06-07	23,114	—	$0	23,114	SEC↗
NGM NGM BIOPHARMACEUTICALS INC	D To issuer deriv	2024-04-05	2024-04-08	39,515	—	$0	0	SEC↗
NGM NGM BIOPHARMACEUTICALS INC	D To issuer deriv	2024-04-05	2024-04-08	19,619	—	$0	0	SEC↗
NGM NGM BIOPHARMACEUTICALS INC	D To issuer deriv	2024-04-05	2024-04-08	24,222	—	$0	0	SEC↗
NGM NGM BIOPHARMACEUTICALS INC	D To issuer deriv	2024-04-05	2024-04-08	78,407	—	$0	0	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2024-02-14	2024-02-15	1,405	$17.79	$25.0K	143,605	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2024-02-13	2024-02-15	2,784	$17.29	$48.1K	145,010	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2024-01-10	2024-01-12	4,668	$19.02	$88.8K	147,794	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2024-01-05	2024-01-09	9,972	$19.43	$193.8K	198,777	SEC↗
DNLI Denali Therapeutics Inc.	A Award deriv	2024-01-03	2024-01-05	161,160	—	$0	161,160	SEC↗
DNLI Denali Therapeutics Inc.	A Award	2024-01-03	2024-01-05	53,720	—	$0	162,434	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2023-08-23	2023-08-25	2,522	$23.22	$58.6K	182,809	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2023-08-21	2023-08-23	2,478	$22.60	$56.0K	185,331	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2023-08-14	2023-08-16	2,768	$23.79	$65.9K	182,809	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2023-08-10	2023-08-14	2,857	$24.15	$69.0K	185,577	SEC↗
BEAM Beam Therapeutics Inc.	A Award deriv	2023-06-06	2023-06-08	16,532	—	$0	16,532	SEC↗
NGM NGM BIOPHARMACEUTICALS INC	A Award deriv	2023-05-10	2023-05-12	78,407	—	$0	78,407	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2023-02-15	2023-02-17	1,476	$29.40	$43.4K	182,809	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2023-02-13	2023-02-14	2,548	$30.10	$76.7K	184,285	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2023-02-10	2023-02-14	818	$29.80	$24.4K	179,365	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2023-02-08	2023-02-10	1,521	$30.88	$47.0K	180,183	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2023-01-09	2023-01-10	1,459	$28.48	$41.6K	177,454	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2023-01-06	2023-01-09	1,451	$28.67	$41.6K	178,913	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2023-01-05	2023-01-09	2,636	$28.44	$75.0K	180,364	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2023-01-04	2023-01-05	2,913	$28.69	$83.6K	175,500	SEC↗
DNLI Denali Therapeutics Inc.	A Award deriv	2023-01-03	2023-01-05	123,360	—	$0	123,360	SEC↗
DNLI Denali Therapeutics Inc.	A Award	2023-01-03	2023-01-05	41,120	—	$0	138,967	SEC↗
BEAM Beam Therapeutics Inc.	A Award deriv	2022-09-01	2022-09-02	10,391	—	$0	10,391	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2022-08-23	2022-08-25	2,424	$31.98	$77.5K	170,663	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2022-08-19	2022-08-23	2,576	$33.22	$85.6K	173,087	SEC↗
DNLI Denali Therapeutics Inc.	A Award	2022-08-09	2022-08-11	22,500	—	$0	110,597	SEC↗
NGM NGM BIOPHARMACEUTICALS INC	A Award deriv	2022-05-18	2022-05-20	24,222	—	$0	24,222	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2022-02-11	2022-02-15	2,918	$34.71	$101.3K	170,663	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2022-02-09	2022-02-11	1,423	$37.10	$52.8K	166,112	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2022-01-05	2022-01-07	2,845	$44.78	$127.4K	163,285	SEC↗
DNLI Denali Therapeutics Inc.	A Award deriv	2022-01-03	2022-01-05	93,000	—	$0	93,000	SEC↗
DNLI Denali Therapeutics Inc.	A Award	2022-01-03	2022-01-05	31,000	—	$0	107,316	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2021-12-06	2021-12-08	1,476	$42.52	$62.8K	76,316	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2021-08-23	2021-08-25	6,143	$48.91	$300.5K	158,630	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2021-08-19	2021-08-23	1,402	$49.31	$69.1K	165,917	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2021-08-19	2021-08-23	1,144	$49.91	$57.1K	164,773	SEC↗
BEAM Beam Therapeutics Inc.	A Award deriv	2021-06-10	2021-06-14	6,877	—	$0	6,877	SEC↗
NGM NGM BIOPHARMACEUTICALS INC	A Award deriv	2021-06-08	2021-06-10	19,619	—	$0	19,619	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2021-03-29	2021-03-31	2,822	$54.62	$154.1K	162,319	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2021-03-01	2021-03-03	125	$70.07	$8.8K	165,209	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2021-03-01	2021-03-03	1,327	$64.54	$85.6K	170,906	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2021-03-01	2021-03-03	2,871	$65.74	$188.7K	168,035	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2021-03-01	2021-03-03	1,173	$67.07	$78.7K	166,862	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2021-03-01	2021-03-03	1,320	$68.01	$89.8K	165,542	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2021-03-01	2021-03-03	208	$68.87	$14.3K	165,334	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2021-03-01	2021-03-03	68	$71.27	$4.8K	165,141	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2021-02-11	2021-02-16	400	$71.49	$28.6K	172,233	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2021-02-11	2021-02-16	2,756	$70.17	$193.4K	172,633	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2021-02-09	2021-02-11	364	$75.10	$27.3K	168,021	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2021-02-09	2021-02-11	100	$76.00	$7.6K	167,921	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2021-02-09	2021-02-11	1,006	$74.40	$74.8K	168,385	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2021-02-07	2021-02-11	4,250	—	$0	8,500	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2021-02-07	2021-02-11	4,250	—	$0	169,391	SEC↗
DNLI Denali Therapeutics Inc.	A Award deriv	2021-01-04	2021-01-06	30,000	—	$0	30,000	SEC↗
DNLI Denali Therapeutics Inc.	A Award deriv	2021-01-04	2021-01-06	90,000	—	$0	90,000	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2020-10-09	2020-10-13	30,000	—	$0	38,240	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2020-10-09	2020-10-13	10,465	$40.68	$425.7K	186,152	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2020-10-09	2020-10-13	30,000	$5.28	$158.4K	196,617	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2020-10-09	2020-10-13	19,535	$41.51	$810.9K	166,617	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2020-10-08	2020-10-13	13,020	—	$0	44,035	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2020-10-08	2020-10-13	9,886	—	$0	68,240	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2020-10-08	2020-10-13	22,906	$5.28	$120.9K	189,523	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2020-10-08	2020-10-13	22,906	$40.12	$919.0K	166,617	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2020-09-10	2020-09-14	3,689	$31.00	$114.4K	165,141	SEC↗
DNLI Denali Therapeutics Inc.	F Tax w/h	2020-08-21	2020-08-24	1,954	$32.88	$64.2K	6,511	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2020-08-20	2020-08-24	5,643	—	$0	0	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2020-08-20	2020-08-24	5,643	—	$0	8,465	SEC↗
DNLI Denali Therapeutics Inc.	A Award deriv	2020-08-18	2020-08-20	20,000	—	$0	20,000	SEC↗
NGM NGM BIOPHARMACEUTICALS INC	A Award deriv	2020-06-05	2020-06-09	39,515	—	$0	39,515	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2020-03-30	2020-04-01	1,428	$19.48	$27.8K	2,822	SEC↗
DNLI Denali Therapeutics Inc.	A Award deriv	2020-02-10	2020-02-12	29,874	—	$0	29,874	SEC↗
DNLI Denali Therapeutics Inc.	A Award deriv	2020-02-10	2020-02-12	142,000	—	$0	142,000	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2020-02-07	2020-04-01	4,250	—	$0	12,750	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2020-02-07	2020-04-01	4,250	—	$0	4,250	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-12-23	2019-12-23	3,464	$20.01	$69.3K	0	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-12-20	2019-12-23	860	$20.00	$17.2K	3,464	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-12-19	2019-12-23	2,566	$20.00	$51.3K	4,324	SEC↗
DNLI Denali Therapeutics Inc.	F Tax w/h	2019-08-21	2019-08-22	2,834	$18.59	$52.7K	49,684	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2019-08-20	2019-08-22	5,643	—	$0	5,643	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2019-08-20	2019-08-22	5,643	—	$0	52,518	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2019-07-08	2019-07-10	2,604	—	$0	92,565	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2019-07-08	2019-07-10	3,907	—	$0	78,126	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-07-08	2019-07-10	2,604	$19.93	$51.9K	4,081	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2019-07-08	2019-07-10	2,604	$5.28	$13.7K	6,685	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2019-07-08	2019-07-10	3,907	$5.28	$20.6K	7,988	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-07-08	2019-07-10	3,907	$20.55	$80.3K	4,081	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-07-08	2019-07-10	9,889	$20.21	$199.9K	81,034	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-07-08	2019-07-10	1,100	$20.88	$23.0K	79,934	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2019-06-10	2019-06-12	711	—	$0	95,169	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2019-06-10	2019-06-12	3,906	—	$0	82,033	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2019-06-10	2019-06-12	3,906	$5.28	$20.6K	3,906	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-06-10	2019-06-12	12,883	$18.78	$241.9K	90,923	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2019-06-10	2019-06-12	711	$5.28	$3.8K	711	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-06-10	2019-06-12	3,906	$18.81	$73.5K	0	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-06-10	2019-06-12	711	$18.62	$13.2K	0	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2019-05-10	2019-05-10	2,546	—	$0	85,939	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-05-10	2019-05-10	3,316	$22.16	$73.5K	103,806	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-05-10	2019-05-10	2,546	$22.17	$56.4K	0	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2019-05-10	2019-05-10	2,546	$5.28	$13.4K	2,546	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2019-05-09	2019-05-10	2,653	—	$0	88,485	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-05-09	2019-05-10	200	$23.58	$4.7K	0	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-05-09	2019-05-10	200	$23.60	$4.7K	107,122	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-05-09	2019-05-10	3,010	$22.83	$68.7K	107,322	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-05-09	2019-05-10	2,453	$22.86	$56.1K	200	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2019-05-09	2019-05-10	2,653	$5.28	$14.0K	2,653	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2019-05-08	2019-05-10	2,613	—	$0	91,138	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2019-05-08	2019-05-10	2,613	$5.28	$13.8K	2,613	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-05-08	2019-05-10	3,162	$23.51	$74.3K	110,332	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-05-08	2019-05-10	2,613	$23.50	$61.4K	0	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-04-04	2019-04-08	8,155	$26.24	$214.0K	114,927	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-04-04	2019-04-08	1,433	$27.00	$38.7K	113,494	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2019-04-03	2019-04-03	5,862	—	$0	93,858	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2019-04-03	2019-05-10	5,862	—	$0	93,751	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2019-04-03	2019-04-03	5,862	$5.28	$31.0K	5,862	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-04-03	2019-04-03	5,262	$26.27	$138.2K	600	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-04-03	2019-04-03	600	$26.81	$16.1K	0	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-04-03	2019-04-03	8,688	$26.29	$228.4K	123,982	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-04-03	2019-04-03	900	$26.79	$24.1K	123,082	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-04-03	2019-05-10	5,262	$26.27	$138.2K	600	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2019-04-03	2019-05-10	5,862	$5.28	$31.0K	5,862	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-04-03	2019-05-10	900	$26.79	$24.1K	123,082	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-04-03	2019-05-10	600	$26.81	$16.1K	0	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-04-03	2019-05-10	8,688	$26.29	$228.4K	123,982	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2019-04-02	2019-04-03	6,135	—	$0	99,720	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2019-04-02	2019-05-10	6,242	—	$0	99,613	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-04-02	2019-04-03	9,445	$25.29	$238.9K	132,670	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-04-02	2019-04-03	3,335	$25.15	$83.9K	0	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-04-02	2019-04-03	2,800	$24.51	$68.6K	3,335	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2019-04-02	2019-04-03	6,135	$5.28	$32.4K	6,135	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-04-02	2019-05-10	9,445	$25.29	$238.9K	132,670	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-04-02	2019-05-10	3,442	$25.15	$86.6K	0	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2019-04-02	2019-05-10	6,242	$5.28	$33.0K	6,242	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-04-02	2019-05-10	2,800	$24.51	$68.6K	3,442	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2019-04-01	2019-04-03	5,775	—	$0	105,855	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2019-04-01	2019-05-10	5,775	—	$0	105,855	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-04-01	2019-04-03	5,775	$23.91	$138.1K	0	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2019-04-01	2019-04-03	5,775	$5.28	$30.5K	5,775	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-04-01	2019-05-10	5,775	$23.91	$138.1K	0	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2019-04-01	2019-05-10	5,775	$5.28	$30.5K	5,775	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2019-03-14	2019-03-18	500	—	$0	111,630	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-03-14	2019-03-18	500	$25.01	$12.5K	142,115	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-03-14	2019-03-18	500	$25.01	$12.5K	0	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2019-03-14	2019-03-18	500	$5.28	$2.6K	500	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2019-03-05	2019-03-05	5,862	—	$0	112,130	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-03-05	2019-03-05	5,862	$21.96	$128.7K	0	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2019-03-05	2019-03-05	5,862	$5.28	$31.0K	5,862	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2019-03-04	2019-03-05	5,863	—	$0	117,992	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-03-04	2019-03-05	4,263	$21.87	$93.2K	1,600	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-03-04	2019-03-05	1,600	$22.84	$36.5K	0	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2019-03-04	2019-03-05	5,863	$5.28	$31.0K	5,863	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2019-03-01	2019-03-05	5,775	—	$0	123,855	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-03-01	2019-03-05	3,824	$22.17	$84.8K	1,951	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-03-01	2019-03-05	1,951	$22.92	$44.7K	0	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2019-03-01	2019-03-05	5,775	$5.28	$30.5K	5,775	SEC↗
DNLI Denali Therapeutics Inc.	A Award deriv	2019-02-07	2019-02-11	136,000	—	$0	136,000	SEC↗
DNLI Denali Therapeutics Inc.	A Award deriv	2019-02-07	2019-02-11	17,000	—	$0	17,000	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2019-02-05	2019-02-05	7,856	—	$0	129,630	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2019-02-05	2019-02-05	7,856	$5.28	$41.5K	7,856	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-02-05	2019-02-05	7,856	$18.83	$147.9K	0	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2019-02-04	2019-02-05	730	—	$0	95,880	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2019-02-04	2019-02-05	3,139	—	$0	137,486	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2019-02-04	2019-02-05	730	$5.28	$3.9K	730	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2019-02-04	2019-02-05	3,139	$5.28	$16.6K	3,869	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-02-04	2019-02-05	769	$19.11	$14.7K	0	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-02-04	2019-02-05	3,100	$18.49	$57.3K	769	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2019-02-01	2019-02-05	5,775	—	$0	96,610	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-02-01	2019-02-05	5,775	$18.64	$107.6K	0	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2019-02-01	2019-02-05	5,775	$5.28	$30.5K	5,775	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2019-01-04	2020-11-30	5,950	—	$0	66,875	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2019-01-04	2020-11-30	5,950	$5.28	$31.4K	184,075	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-01-04	2020-11-30	4,450	$20.03	$89.1K	178,125	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-01-04	2020-11-30	1,500	$19.30	$28.9K	182,575	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2019-01-04	2019-01-04	5,950	—	$0	102,385	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-01-04	2019-01-04	1,500	$19.30	$28.9K	7,227	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2019-01-04	2019-01-04	5,950	$5.28	$31.4K	8,727	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-01-04	2019-01-04	4,450	$20.03	$89.1K	2,777	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2019-01-03	2020-11-30	5,775	—	$0	72,825	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2019-01-03	2020-11-30	5,775	$5.28	$30.5K	183,900	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-01-03	2020-11-30	5,775	$18.90	$109.1K	178,125	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2019-01-03	2019-01-04	5,775	—	$0	108,335	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-01-03	2019-01-04	2,777	$18.90	$52.5K	2,777	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2019-01-03	2019-01-04	5,775	$5.28	$30.5K	8,552	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2019-01-02	2020-11-30	5,775	—	$0	78,600	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-01-02	2020-11-30	4,875	$19.43	$94.7K	179,025	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2019-01-02	2020-11-30	5,775	$5.28	$30.5K	183,900	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-01-02	2020-11-30	900	$20.24	$18.2K	178,125	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-01-02	2019-01-04	900	$20.24	$18.2K	142,615	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2019-01-02	2019-01-04	4,875	$19.43	$94.7K	143,515	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2018-12-03	2020-11-30	17,500	—	$0	84,375	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2018-12-03	2020-11-30	17,500	$5.28	$92.4K	195,625	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2018-12-03	2020-11-30	400	$19.16	$7.7K	178,125	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2018-12-03	2020-11-30	17,100	$18.43	$315.2K	178,525	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2018-12-03	2018-12-06	400	$19.16	$7.7K	148,390	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2018-12-03	2018-12-06	17,100	$18.43	$315.2K	148,790	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise deriv	2018-11-15	2020-11-30	12,235	—	$0	101,875	SEC↗
DNLI Denali Therapeutics Inc.	M Exercise	2018-11-15	2020-11-30	12,235	$5.28	$64.6K	195,625	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2018-11-15	2020-11-30	17,500	$18.07	$316.2K	178,125	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2018-11-15	2018-11-19	17,500	$18.07	$316.2K	165,890	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2018-10-01	2018-10-03	17,500	$21.72	$380.1K	183,390	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2018-09-04	2018-09-06	17,500	$19.05	$333.4K	200,890	SEC↗
DNLI Denali Therapeutics Inc.	S Sale	2018-08-29	2018-08-31	17,500	$18.04	$315.7K	218,390	SEC↗
DNLI Denali Therapeutics Inc.	A Award deriv	2018-08-20	2018-08-22	11,286	—	$0	11,286	SEC↗
DNLI Denali Therapeutics Inc.	A Award deriv	2018-02-26	2018-02-28	180,000	—	$0	180,000	SEC↗